AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bdpalbo 125mg Capsule

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Palbociclib (125mg)

Overview Bdpalbo 125mg Capsule

Palbociclib 125mg capsules are indicated for treating specific metastatic breast cancers (estrogen receptor-positive, HER2-negative). This medication is administered concomitantly with endocrine therapy. Consume Palbociclib 125mg capsules with food, aiming for consistent daily timing to maximize efficacy. Dosage and frequency are determined by your physician, tailored to your individual needs and subject to adjustment. Strict adherence to your prescribed regimen is crucial; improper use or overdose may lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue use only upon your doctor's instruction. Common side effects include tiredness, alopecia, skin rashes, nausea, and diarrhea. This medication can reduce blood cell counts (red and white), increasing infection risk. Report any signs of infection (fever, chills, weakness, bleeding, bruising, epistaxis) to your doctor immediately. Dizziness is a potential side effect; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including antibiotics, to your physician. Drug interactions are possible; inform your healthcare provider of all concurrent medications. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout treatment to prevent conception.

Uses of Bdpalbo 125mg Capsule

Malignancy of the mammary gland

Major Benefits of Bdpalbo 125mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 125mg Bdpalbo capsule with a meal.

Common Side effects of Bdpalbo 125mg Capsule:

  • Decreased blood cells (red cells, white cells, and platelets)
  • Fatigue
  • Hair loss
  • Rash
  • Vomiting
  • Diarrhea
  • Nausea
  • Decreased appetite
  • Infection
  • Decreased white blood cell count
  • Stomatitis (Inflammation of the mouth)
  • Anemia (low number of red blood cells)
  • Weakness
  • Fever

How to use Bdpalbo 125mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume the Bdpalbo 125mg Capsule with food.

How Bdpalbo 125mg Capsule works:

Palbociclib 125mg capsules are an anticancer drug. They function by blocking cyclin-dependent kinases 4 and 6, enzymes crucial in cellular proliferation signaling pathways. This action halts the cancerous cell growth cycle. The medication also specifically targets estrogen receptor-positive breast cancer cells, interfering with their cell cycle progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of alcohol consumption alongside Bdpalbo 125mg Capsule is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Bdpalbo 125mg capsules during pregnancy poses a confirmed risk to the fetus. Prescribing it is unlikely except in critical circumstances where the potential benefits clearly outweigh the dangers. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and the use of Bdpalbo 125mg capsules are incompatible due to the potential for infant harm. Research indicates a risk of neonatal toxicity.

DrivingDrivingUNSAFE

Taking Bdpalbo 125mg Capsules might lead to adverse reactions impacting driving capabilities. Drowsiness is a potential side effect. Therefore, operate vehicles or machinery with extra care if affected.

KidneyKidneySAFE IF PRESCRIBED

Bdpalbo 125mg capsules may be administered to patients with renal impairment without requiring modification of the dosage.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Bdpalbo 125mg Capsules. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Bdpalbo 125mg Capsule :

NA

Facts to Know About Bdpalbo 125mg Capsule

LabelValue
Type of Compound Piperazine-pyridines
Potential for Dependence None.
Type of Treatment Cancer therapeutics
Mechanism of Action Cell Cycle Kinase Regulator

FAQs on Bdpalbo 125mg Capsule

Palbociclib 125mg capsules are an anticancer medication. This medication functions by inhibiting cyclin-dependent kinase proteins. This inhibition reduces the rate of cancer cell proliferation and hinders disease advancement.
Treatment length differs individually. Your physician will determine the necessary treatment course based on your health status, treatment response, and side effect tolerance. They may reduce your dosage or halt treatment, either temporarily or permanently, should specific side effects occur.
Discontinuation of Bdpalbo 125mg Capsule typically resolves most adverse reactions. A known side effect is neutropenia, characterized by a decrease in white blood cells, leading to immune system compromise and increased infection susceptibility. This effect, however, is usually transient and resolves quickly upon cessation of treatment.
Blood monitoring is crucial because this medication may reduce blood cell levels. Regular blood tests assess Bdpalbo 125mg Capsule's impact on white blood cells, red blood cells, and platelets. These tests are scheduled for the start of each chemotherapy cycle, day fifteen of the initial two cycles, and as deemed medically necessary.
Bdpalbo 125mg capsules are typically administered once daily for three weeks, followed by a one-week treatment-free period, completing a 28-day cycle. Consume the medication with food at the same time each day. Swallow the capsules whole; avoid crushing, chewing, or opening them. Discard any damaged or broken capsules. If vomiting occurs after ingestion, refrain from taking a replacement dose and resume the usual schedule.
Females capable of bearing children undergoing treatment with Bdpalbo 125mg Capsules, and their partners, must employ reliable contraception (for example, a dual-barrier approach like condoms and diaphragms). This contraceptive practice should continue throughout treatment and for a minimum of three weeks post-treatment for women. Males receiving Bdpalbo 125mg Capsules must utilize birth control for at least fourteen weeks following treatment cessation.
Treatment with Bdpalbo 125mg Capsule may impact male reproductive capacity. Therefore, men undergoing this therapy should contemplate sperm banking beforehand.
Taking Bdpalbo 125mg Capsules may result in severe adverse reactions such as breathlessness, lightheadedness, fatigue, and unexpected bleeding (including nosebleeds). Fever, shivering, infection indicators, and a rapid, erratic, or forceful pulse are also potential side effects. Seek immediate medical attention or contact your physician if any of these occur.
Bdpalbo 125mg Capsule
3,664
MRP 4,464
17% off